EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Prognosis and Long‐Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis

Georgina Maalouf iD, Bérangère Arnould, Olivier Espitia iD, Hubert Deboysson iD, Maxime Samson, Arnaud Hot, Eric Liozon, Simon Parreau, Christian Lavigne, Valentin Lacombe, Jean-Francois Alexandra, Thomas Thibault und 25 weitere

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70101 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Georgina Maalouf und 36 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, and Centre Nation…. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Stroke, Myocardial Infarction. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Large vessel‐vasculitis (LVV) accounts for up to 70% of patients with giant cell arteritis (GCA). Stenotic involvement in GCA‐LVV remains largely unknown. The purpose of this study was to assess the long‐term outcome and prognosis of GCA with stenotic LVV.

Methods

This was a retrospective multicenter study of 3,149 patients with GCA, including 198 (6.3%) with stenotic LVV. Hierarchical clustering on principal components was performed on baseline arterial localizations and logistic regression assessed factors associated with vascular complications.

Results

Stenotic LVV affected mostly the subclavian artery (63%), the carotid artery (58%), vertebral artery (37%), and axillary artery (33%), followed by the femoral artery (30%) and mesenteric arteries (13%). Stroke (31%) was the main complication, followed by limb ischemia (21%), myocardial infarction (4%), and mesenteric ischemia (2%). Cumulative incidence of vascular complications was 13.1% (95% confidence interval [CI] 8.9–18.3), 17.3% (95% CI 12.3–22.9), and 19.5% (95% CI 14.3–25.4), at 1, 5, and 10 years, respectively. Hierarchical clustering analysis identified three clusters among which cluster 1 (n = 123; 62%) included older patients with more arteritic anterior ischemic optic neuropathy ( P = 0.04), vertebral artery stenosis, and a higher mortality rate ( P < 0.044). In multivariate analysis, age at diagnosis (hazard ratio [HR] 1.06, 95% CI 1.03–1.10; P = 0.0004) and vertebral involvement (HR 1.87, 95% CI 1.03–3.40; P = 0.039) were significantly associated with higher risk of vascular complication.

Conclusion

Stenotic LVV accounts for less than 10% of GCA and is associated with poor vascular prognosis. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisStrokeMyocardial InfarctionHumansFemaleRetrospective StudiesPrognosisMaleAgedAged, 80 and overAxillary ArterySubclavian ArteryVertebral ArteryFemoral ArteryMesenteric ArteriesMiddle AgedConstriction, PathologicIschemia

Autor:innen und Institutionen

  • Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, and Centre National de Références Maladies Autoimmunes Systémiques Rares, Centre Nation…
  • Department of Internal Medicine, CHU Rouen, Rouen, France.
  • Department of Vascular Medicine, CHU Nantes, Nantes, France.
  • Department of Internal Medicine, CHU Caen, Caen, France.
  • Internal Medicine and Systemic Disease Unit, CHU Dijon, Dijon, Burgundy, France.
  • Department of Internal Medicine, Hôpital Edouard-Herriot, Lyon, France.

ORCID-Profile: Georgina Maalouf, Olivier Espitia, Hubert Deboysson, Matthieu Groh, Cécile-Audrey Durel, Thibaud Chazal, Anael Dumont, Valérie Devauchelle-Pensec, Patrice Cacoub

Zitieren

APA

Maalouf, G., Arnould, B., Espitia, O., Deboysson, H., Samson, M., Hot, A., Liozon, E., Parreau, S., Lavigne, C., Lacombe, V., Alexandra, J. F., Thibault, T., Chiche, L., Gaudric, J., Redheuil, A., Vieira, M., Groh, M., Durel, C. A., Chazal, T., …, & GEFA (French Study Group for Large Vessel Vasculitis) (2026). Prognosis and Long‐Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.70101

Vancouver

Maalouf G, Arnould B, Espitia O, Deboysson H, Samson M, Hot A, et al. Prognosis and Long‐Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis. Arthritis & Rheumatology. 2026. doi:10.1002/art.70101

BibTeX
@article{Maalouf2026,
  author = {Maalouf, Georgina and Arnould, Bérangère and Espitia, Olivier and Deboysson, Hubert and Samson, Maxime and Hot, Arnaud and Liozon, Eric and Parreau, Simon and Lavigne, Christian and Lacombe, Valentin and Alexandra, Jean-Francois and Thibault, Thomas and Chiche, Laurent and Gaudric, Julien and Redheuil, Alban and Vieira, Matheus and Groh, Matthieu and Durel, Cécile-Audrey and Chazal, Thibaud and Comarmond, Chloé and Magy-Bertrand, Nadine and Vinzio, Stéphane and Martzolff, Lionel and Lozac'h, Pierre and Outh, Rodérau and Clément, Jérémy and Duffau, Pierre and Dumont, Anael and Humbert, Sebastien and Guillaud, Constance and Dellal, Azeddine and Pugnet, Grégory and Devauchelle-Pensec, Valérie and Cacoub, Patrice and Biard, Lucie and Saadoun, David and GEFA (French Study Group for Large Vessel Vasculitis), GEFA (French Study Group for Large Vessel Vasculitis)},
  title = {Prognosis and Long‐Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70101}
}
Kostenlos starten →